BILL · 2015–16 SESSION

HB 2363: Rx drug cost and utilization

Concerning pharmaceutical drug cost and utilization transparency.

Summary

Requires the lead organization for the all payer claims database (APCD) to report specific information about spending on prescription drugs, including amounts spent by government entities, the highest cost drugs, and spending trends.
Requires manufacturers of drugs that meet a specific cost threshold to report several cost components related to each drug's production to the Office of Financial Management and the lead organization for the APCD.

From the House Bill Analysis 2016 (HB 2363), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to pharmaceutical drug cost and utilization transparency;

No recorded floor votes. This measure never reached a floor vote.

Mar 10, 2016By resolution, reintroduced and retained in present status.
Jan 11, 2016First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
Jan 8, 2016Prefiled for introduction.

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 2363 (2025–26) Music therapy exemptions · Enacted · Chapter 27, Laws of 2026
HB 2363 (2023–24) Alcohol/pop-up retail sales · Did not pass · died in committee
HB 2363 (2019–20) Biometric data remedies · Did not pass · stalled on the House floor
HB 2363 (2017–18) Contraband/unmanned aircraft · Did not pass · passed House, stalled in Senate
HB 2363 (2013–14) Military member dependents · Enacted · Chapter 180, Laws of 2014
HB 2363 (2011–12) Domestic violence victims · Enacted · Chapter 223, Laws of 2012
HB 2363 (2009–10) Educational employees · Enacted · Chapter 573, Laws of 2009
HB 2363 (2007–08) Electronic waste · Did not pass · died in committee